The exact mechanisms driving efficacy of GLP-1 receptor agonists in obesity are unknown, as the effects are widespread and include delayed gastric emptying and changes in blood glucose (193). Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.